Suppr超能文献

射血分数降低的慢性心力衰竭患者舒张期壁应变的预后价值。

Prognostic value of diastolic wall strain in patients with chronic heart failure with reduced ejection fraction.

作者信息

Soyama Yuko, Mano Toshiaki, Goda Akiko, Sugahara Masataka, Masai Kumiko, Masuyama Tohru

机构信息

Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

出版信息

Heart Vessels. 2017 Jan;32(1):68-75. doi: 10.1007/s00380-016-0838-6. Epub 2016 Apr 26.

Abstract

Left ventricular (LV) diastolic dysfunction plays a crucial role in heart failure with reduced ejection fraction (HFrEF). LV stiffness is a main component of diastolic function, but its role and prognostic value in HFrEF patients remains unclear. This study aimed to determine whether diastolic wall strain (DWS) as a noninvasive and simple marker of LV stiffness can predict the prognosis of HFrEF patients who were administrated chronic beta blockade enough. We enrolled 75 HFrEF patients who were administrated chronic beta blockade. We evaluated the echocardiographic parameters and plasma brain natriuretic peptide (BNP) before the induction of beta blockade and also obtained pulmonary artery wedge pressure (PAWP) from the right heart catheterization. DWS was obtained from standard M-mode echocardiography as follows: DWS = [(LV posterior wall thickness (LVPWT) at end-systole - LVPWT at end-diastole)/LVPWT] at end-systole. DWS did not correlate with other echocardiographic parameters and PAWP. We defined primary outcome as HF hospitalization or cardiovascular death and followed for 7 years. The incidence rate was higher in low DWS than high DWS patients (p = 0.04). Other echocardiographic parameters could not be significant predictors of HFrEF outcome under the condition of enough beta blocker therapy. In multivariate analysis, DWS was the independent contributor to the event-free time. Impaired LV stiffness evaluated with DWS was associated with worse outcome and DWS might be an independent prognostic factor in HFrEF patients with chronic beta blockade.

摘要

左心室舒张功能障碍在射血分数降低的心力衰竭(HFrEF)中起关键作用。左心室僵硬度是舒张功能的主要组成部分,但其在HFrEF患者中的作用和预后价值仍不清楚。本研究旨在确定作为左心室僵硬度无创且简单标志物的舒张期壁应变(DWS)是否可预测接受足够慢性β受体阻滞剂治疗的HFrEF患者的预后。我们纳入了75例接受慢性β受体阻滞剂治疗的HFrEF患者。我们在开始β受体阻滞剂治疗前评估了超声心动图参数和血浆脑钠肽(BNP),并通过右心导管检查获得了肺动脉楔压(PAWP)。DWS通过标准M型超声心动图获得,方法如下:DWS = [(收缩末期左心室后壁厚度(LVPWT) - 舒张末期LVPWT)/收缩末期LVPWT]。DWS与其他超声心动图参数和PAWP均无相关性。我们将主要结局定义为心力衰竭住院或心血管死亡,并随访7年。低DWS患者的发生率高于高DWS患者(p = 0.04)。在足够的β受体阻滞剂治疗条件下,其他超声心动图参数不能显著预测HFrEF结局。在多变量分析中,DWS是无事件时间的独立影响因素。用DWS评估的左心室僵硬度受损与更差的结局相关,DWS可能是接受慢性β受体阻滞剂治疗的HFrEF患者的独立预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验